Cargando…

Author Correction: Neoantigen-specific stem cell memory-like CD4(+) T cells mediate CD8(+) T cell-dependent immunotherapy of MHC class II-negative solid tumors

Detalles Bibliográficos
Autores principales:	Brightman, Spencer E., Becker, Angelica, Thota, Rukman R., Naradikian, Martin S., Chihab, Leila, Zavala, Karla Soria, Ramamoorthy Premlal, Ashmitaa Logandha, Griswold, Ryan Q., Dolina, Joseph S., Cohen, Ezra E. W., Miller, Aaron M., Peters, Bjoern, Schoenberger, Stephen P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group US 2023
Materias:	Author Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10382305/ https://www.ncbi.nlm.nih.gov/pubmed/37464051 http://dx.doi.org/10.1038/s41590-023-01591-1

Ejemplares similares

Neoantigen-specific stem cell memory-like CD4(+) T cells mediate CD8(+) T cell-dependent immunotherapy of MHC class II-negative solid tumors
por: Brightman, Spencer E., et al.
Publicado: (2023)

Linked CD4(+)/CD8(+) T cell neoantigen vaccination overcomes immune checkpoint blockade resistance and enables tumor regression
por: Dolina, Joseph S., et al.
Publicado: (2023)

Tumor cells fail to present MHC-II–restricted epitopes derived from oncogenes to CD4(+) T cells
por: Brightman, Spencer E., et al.
Publicado: (2023)

Predicting T cell recognition of MHC class I restricted neoepitopes
por: Koşaloğlu-Yalçın, Zeynep, et al.
Publicado: (2018)

T Cell Responses to Neural Autoantigens Are Similar in Alzheimer’s Disease Patients and Age-Matched Healthy Controls
por: Dhanwani, Rekha, et al.
Publicado: (2020)

Corrigendum: T Cell Responses to Neural Autoantigens Are Similar in Alzheimer's Disease Patients and Age-Matched Healthy Controls
por: Dhanwani, Rekha, et al.
Publicado: (2021)

Transcriptome and chromatin landscape of iNKT cells are shaped by subset differentiation and antigen exposure
por: Murray, Mallory Paynich, et al.
Publicado: (2021)

TLR9 Sensing of Self-DNA Controls Cell-Mediated Immunity to Listeria Infection via Rapid Conversion of Conventional CD4(+) T Cells to T(reg)
por: Dolina, Joseph S., et al.
Publicado: (2020)

Developmentally distinct CD4(+) T(reg) lineages shape the CD8(+) T cell response to acute Listeria infection
por: Dolina, Joseph S., et al.
Publicado: (2022)

Mucosal CD8 Memory T Cells are selected in the periphery by an MHC Class I Molecule
por: Huang, Yujun, et al.
Publicado: (2011)

Both CD8 and CD4 T cells contribute to immunosurveillance preventing the development of neoantigen-expressing autochthonous sarcomas
por: Himes, Jonathon E., et al.
Publicado: (2023)

Identification of patient-specific CD4(+) and CD8(+) T cell neoantigens through HLA-unbiased genetic screens
por: Cattaneo, Chiara M., et al.
Publicado: (2023)

Selection of Shared and Neoantigen-Reactive T Cells for Adoptive Cell Therapy Based on CD137 Separation
por: Seliktar-Ofir, Sivan, et al.
Publicado: (2017)

CD8(+) T Cell Exhaustion in Cancer
por: Dolina, Joseph S., et al.
Publicado: (2021)

MHC control of CD4+ T cell subset activation
Publicado: (1989)

Identification of a CD8+ T-cell response to a predicted neoantigen in malignant mesothelioma
por: Sneddon, Sophie, et al.
Publicado: (2019)

CD103 and CD39 coexpression identifies neoantigen-specific cytotoxic T cells in colorectal cancers with low mutation burden
por: van den Bulk, Jitske, et al.
Publicado: (2023)

Class-B CpG-ODN Formulated With a Nanostructure Induces Type I Interferons-Dependent and CD4(+) T Cell-Independent CD8(+) T-Cell Response Against Unconjugated Protein Antigen
por: Chiodetti, Ana L., et al.
Publicado: (2018)

MHC-II neoantigens shape tumor immunity and response to immunotherapy
por: Alspach, Elise, et al.
Publicado: (2019)

Combined assessment of MHC binding and antigen abundance improves T cell epitope predictions
por: Koşaloğlu-Yalçın, Zeynep, et al.
Publicado: (2022)

Neoantigen-specific CD4(+) T-cell response is critical for the therapeutic efficacy of cryo-thermal therapy
por: Peng, Peng, et al.
Publicado: (2020)

Robust antigen-specific CD8 T cell tolerance to a model prostate cancer neoantigen
por: Lopez-Bujanda, Zoila A., et al.
Publicado: (2020)

Neoantigen-specific CD8 T cells with high structural avidity preferentially reside in and eliminate tumors
por: Schmidt, Julien, et al.
Publicado: (2023)

MHC-based detection of antigen-specific CD8(+) T cell responses
por: Hadrup, Sine Reker, et al.
Publicado: (2010)

Intravenous Nanoparticle Vaccination Generates Stem-Like TCF1(+) Neoantigen-Specific CD8(+) T Cells
por: Baharom, Faezzah, et al.
Publicado: (2020)

Evaluating performance of existing computational models in predicting CD8+ T cell pathogenic epitopes and cancer neoantigens
por: Buckley, Paul R, et al.
Publicado: (2022)

Neoantigen-reactive CD8(+) T cells affect clinical outcome of adoptive cell therapy with tumor-infiltrating lymphocytes in melanoma
por: Kristensen, Nikolaj Pagh, et al.
Publicado: (2022)

Cell surface marker-based capture of neoantigen-reactive CD8(+) T-cell receptors from metastatic tumor digests
por: Chatani, Praveen D, et al.
Publicado: (2023)

High-dose IL-2/CD25 fusion protein amplifies vaccine-induced CD4(+) and CD8(+) neoantigen-specific T cells to promote antitumor immunity
por: Hernandez, Rosmely, et al.
Publicado: (2021)

High-affinity neoantigens correlate with better prognosis and trigger potent antihepatocellular carcinoma (HCC) activity by activating CD39(+)CD8(+) T cells
por: Liu, Ting, et al.
Publicado: (2021)

Polyfunctional CD4(+) T Cell Responses to Immunodominant Epitopes Correlate with Disease Activity of Virulent Salmonella
por: Maybeno, Matt, et al.
Publicado: (2012)

Peripheral blood CD8αα(+)CD11c(+)MHC(−)II(+)CD3- cells attenuate autoimmune glomerulonephritis in rats
por: Wu, Jean, et al.
Publicado: (2013)

The CD8 Population in CD4-deficient Mice Is Heavily Contaminated with MHC Class II–restricted T Cells
por: Tyznik, Aaron J., et al.
Publicado: (2004)

Analysis, Isolation, and Activation of Antigen-Specific CD4(+) and CD8(+) T Cells by Soluble MHC-Peptide Complexes
por: Schmidt, Julien, et al.
Publicado: (2013)

Neoantigen characteristics in the context of the complete predicted MHC class I self-immunopeptidome
por: Brown, Scott D., et al.
Publicado: (2018)

Creating MHC-Restricted Neoantigens with Covalent Inhibitors That Can Be Targeted by Immune Therapy
por: Hattori, Takamitsu, et al.
Publicado: (2023)

Generation of novel complete HLA class I monoallelic cell lines used in an MHC stabilization assay for neoantigen evaluation
por: Iizuka, Akira, et al.
Publicado: (2023)

A lipidated bi-epitope vaccine comprising of MHC-I and MHC-II binder peptides elicits protective CD4 T cell and CD8 T cell immunity against Mycobacterium tuberculosis
por: Rai, Pradeep K., et al.
Publicado: (2018)

The role of ACAID and CD4(+)CD25(+)FOXP3(+) regulatory T cells on CTL function against MHC alloantigens
por: Saban, Daniel R., et al.
Publicado: (2008)

Checkpoint blockade immunotherapy reshapes the high-dimensional phenotypic heterogeneity of murine intratumoural neoantigen-specific CD8(+) T cells
por: Fehlings, M., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_fisvu2ai1rn6jl98a943nqhi42